Latest Synergies News

Australian Oil Co has lifted production at its Emu Apple-1 well to 15–20 barrels of dry oil per day post-acid wash, while advancing infrastructure upgrades at Riverslea and preparing Major Gas Field for near-term output.

Koonenberry Gold has completed its acquisition of the Gundagai Gold-Copper Project, adding 485km2 to its Lachlan Fold Belt portfolio and unlocking multiple high-grade targets for near-term drilling.

Southern Cross Media Group’s FY26 results reveal a 4.5% revenue drop amid a soft advertising market, but $30 million in merger synergies delivered a year early and digital revenue growth offer a silver lining.

Tabcorp Holdings has agreed to acquire BetMakers Technology Group for approximately $267 million, aiming to accelerate its wagering technology upgrade and expand its global B2B footprint. The deal targets $30 million in cost synergies by Year 2 and expects double-digit EPS accretion by Year 3.

James Hardie Industries posted a 64% jump in Q1 FY27 net sales to $1.475 billion, powered by the AZEK acquisition and solid organic growth. The company exceeded EBITDA guidance and raised its full-year outlook, targeting robust sales and cash flow growth amid cautious housing market assumptions.

Tasmea has finalized its acquisition of JPS Group, integrating a specialist energy services provider and boosting its FY27 earnings guidance. The deal adds a skilled workforce, blue-chip clients, and tech-enabled isolation services to Tasmea’s Mechanical segment.

Flynn Gold has inked a non-binding Ore Purchase Agreement with Kaiser Reef's Henty Gold Mine, opening a potential low-capital route to production for its Golden Ridge project in Tasmania.

Promisia Healthcare is set to acquire Chatswood Retirement Village in Christchurch for $25 million, bolstering its East Christchurch presence and promising immediate earnings accretion.

Stakk Ltd's combined pro forma FY2026 revenue with ParaScript has climbed to approximately A$45 million, surpassing earlier forecasts by 9%. Both companies outperformed initial revenue assumptions, setting a stronger baseline ahead of integration benefits.

Amplia Therapeutics has teamed up with Eli Lilly to test its FAK inhibitor narmafotinib alongside Lilly’s KRAS G12C inhibitor olomorasib in advanced non-small cell lung cancer, marking a strategic expansion beyond pancreatic and ovarian cancers.

Marmota Limited is ramping up its maiden drilling program at the Greenewood gold discovery in South Australia, increasing planned drilling from 20,000m to 26,000m to extend mineralisation and support a scoping study.

Austral Resources Australia Ltd has lodged a binding proposal to acquire Hammer Metals, offering a 29.9% premium over a rival bid and proposing a SpinCo demerger of Hammer's WA gold assets. The deal would create a larger, more diversified Queensland copper producer with operational synergies and enhanced exploration potential.